Blood compatibility evaluation of polydopamine nanoparticles

Sha Li1, Si-Ming Yan1, Li-Wei Zhang1

  • 1Zhuhai Key Laboratory of Basic and Applied Research in Chinese Medicine, School of Bioengineering, Zunyi Medical University, Zhuhai, Guangdong, China.

PubMed
Summary

Polydopamine nanoparticles (PDA NPs) impact red blood cells and blood proteins, affecting coagulation and immune responses. While showing no acute organ toxicity, further hemocompatibility studies are crucial for clinical use.

Related Concept Videos